Literature DB >> 22833923

Enhanced delivery of lopinavir to the CNS using Compritol-based solid lipid nanoparticles.

Aji Alex1, Willi Paul, A J Chacko, Chandra P Sharma.   

Abstract

BACKGROUND: Protease inhibitors such as lopinavir have negligible permeability to the CNS due to blood-brain and blood-cerebrospinal fluid interfaces. An attempt has been made to develop solid lipid nanoparticles to increase the availability of lopinavir in the CNS. RESULTS/DISCUSSION: Solid lipid nanoparticle formulations exhibited a Cmax and T(max) of 632.86 +/- 81.61 ng/ml and 25 +/- 7.75 min, respectively, with a significant increase in bioavailability in a rat model compared with a free-drug suspension. An appreciable increase in cerebrospinal fluid concentration was detected with solid lipid nanoparticle formulations.
CONCLUSION: Compritol-based solid lipid nanoparticles with a poloxamer coating can be effectively absorbed through the lymphatic system, prolong the circulation of drug in blood by acting as a reservoir and can effectively target the drug to the CNS due to the combined effect of lipophilicity and surface charge. The high biocompatibility, biodegradability and nontoxicity of compritol make the compritol-based solid lipid nanoparticles an excellent carrier for enhanced CNS delivery of lopinavir.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22833923     DOI: 10.4155/tde.10.96

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  6 in total

1.  Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) Enzymes.

Authors:  Narasimha M Midde; Santosh Kumar
Journal:  J Pers Nanomed       Date:  2015-09-10

Review 2.  Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.

Authors:  Leila Fotooh Abadi; Fouad Damiri; Mehrukh Zehravi; Rohit Joshi; Rohan Pai; Mohammed Berrada; Ehab El Sayed Massoud; Md Habibur Rahman; Satish Rojekar; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-29       Impact factor: 4.967

3.  Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Authors:  Alaa Mohamed Nazief; Passainte Saber Hassaan; Hoda Mahmoud Khalifa; Magda Samir Sokar; Amal Hassan El-Kamel
Journal:  Int J Nanomedicine       Date:  2020-02-18

Review 4.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04

Review 5.  Nanoscale drug delivery systems and the blood-brain barrier.

Authors:  Renad Alyautdin; Igor Khalin; Mohd Ismail Nafeeza; Muhammad Huzaimi Haron; Dmitry Kuznetsov
Journal:  Int J Nanomedicine       Date:  2014-02-07

6.  Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS.

Authors:  Saif Ahmad Khan; Saleha Rehman; Bushra Nabi; Ashif Iqubal; Nida Nehal; Usama A Fahmy; Sabna Kotta; Sanjula Baboota; Shadab Md; Javed Ali
Journal:  Pharmaceutics       Date:  2020-11-06       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.